488 related articles for article (PubMed ID: 26934363)
1. Urocortin attenuates myocardial fibrosis in diabetic rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Li J; Zhang X; Song F; Xu J
Endocr Res; 2016 May; 41(2):148-57. PubMed ID: 26934363
[TBL] [Abstract][Full Text] [Related]
2. Urocortin ameliorates diabetic cardiomyopathy in rats via the Akt/GSK-3β signaling pathway.
Liu X; Liu C; Zhang X; Zhao J; Xu J
Exp Ther Med; 2015 Mar; 9(3):667-674. PubMed ID: 25667611
[TBL] [Abstract][Full Text] [Related]
3. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats.
Yu W; Wu J; Cai F; Xiang J; Zha W; Fan D; Guo S; Ming Z; Liu C
PLoS One; 2012; 7(12):e52013. PubMed ID: 23251674
[TBL] [Abstract][Full Text] [Related]
4. Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
Bulani Y; Sharma SS
Cardiovasc Drugs Ther; 2017 Jun; 31(3):255-267. PubMed ID: 28695302
[TBL] [Abstract][Full Text] [Related]
5. 25-OH-PPD inhibits hypertrophy on diabetic cardiomyopathy via the PI3k/Akt/GSK-3β signaling pathway.
Liu X; Song F; Liu C; Zhang Y
Exp Ther Med; 2020 Sep; 20(3):2141-2147. PubMed ID: 32765689
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy.
Al-Damry NT; Attia HA; Al-Rasheed NM; Al-Rasheed NM; Mohamad RA; Al-Amin MA; Dizmiri N; Atteya M
Biomed Pharmacother; 2018 Nov; 107():347-358. PubMed ID: 30099338
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis of cardiomyocytes in diabetic cardiomyopathy involves overexpression of glycogen synthase kinase-3β.
Wu W; Liu X; Han L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30237226
[TBL] [Abstract][Full Text] [Related]
8. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective effects of tanshinone IIA pretreatment via kinin B2 receptor-Akt-GSK-3β dependent pathway in experimental diabetic cardiomyopathy.
Sun D; Shen M; Li J; Li W; Zhang Y; Zhao L; Zhang Z; Yuan Y; Wang H; Cao F
Cardiovasc Diabetol; 2011 Jan; 10():4. PubMed ID: 21232147
[TBL] [Abstract][Full Text] [Related]
10. Urocortin-induced cardiomyocytes hypertrophy is associated with regulation of the GSK-3β pathway.
Gruson D; Ginion A; Decroly N; Lause P; Vanoverschelde JL; Ketelslegers JM; Bertrand L; Thissen JP
Heart Vessels; 2012 Mar; 27(2):202-7. PubMed ID: 21505854
[TBL] [Abstract][Full Text] [Related]
11. The Effects of Carvedilol on Cardiac Function and the AKT/XIAP Signaling Pathway in Diabetic Cardiomyopathy Rats.
Zheng W; Shang X; Zhang C; Gao X; Robinson B; Liu J
Cardiology; 2017; 136(3):204-211. PubMed ID: 27780169
[TBL] [Abstract][Full Text] [Related]
12. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways.
Xue R; Lei S; Xia ZY; Wu Y; Meng Q; Zhan L; Su W; Liu H; Xu J; Liu Z; Zhou B; Xia Z
Clin Sci (Lond); 2016 Mar; 130(5):377-92. PubMed ID: 26666444
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin inhibits TGF-beta1 expression and alleviates myocardial fibrosis in diabetic rats.
Ma YX; Li WH; Xie Q
Pharmazie; 2013 May; 68(5):355-8. PubMed ID: 23802433
[TBL] [Abstract][Full Text] [Related]
15. Baicalein Protects Rats with Diabetic Cardiomyopathy Against Oxidative Stress and Inflammation Injury via Phosphatidylinositol 3-Kinase (PI3K)/AKT Pathway.
Ma L; Li XP; Ji HS; Liu YF; Li EZ
Med Sci Monit; 2018 Aug; 24():5368-5375. PubMed ID: 30070262
[TBL] [Abstract][Full Text] [Related]
16. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin-D3 prevents the development of diabetic cardiomyopathy in type 1 diabetic rats by enhancing autophagy via inhibiting the β-catenin/TCF4/GSK-3β/mTOR pathway.
Wei H; Qu H; Wang H; Ji B; Ding Y; Liu D; Duan Y; Liang H; Peng C; Xiao X; Deng H
J Steroid Biochem Mol Biol; 2017 Apr; 168():71-90. PubMed ID: 28216152
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats.
Zhang L; Guo Z; Wang Y; Geng J; Han S
Drug Dev Res; 2019 May; 80(3):294-309. PubMed ID: 30864233
[TBL] [Abstract][Full Text] [Related]
20. [Berberine inhibits cardiac fibrosis of diabetic rats].
Lu K; Shen Y; He J; Liu G; Song W
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Oct; 32(10):1352-1355. PubMed ID: 27667461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
